AveXis
Why Robinhood?
You can watch AveXis and buy or sell other stocks, ETFs, and their options commission-free!About AVXS
AveXis , doing business as Novartis Gene Therapies, Inc., is a biotechnology company that specializes in the development and commercialization of gene therapies for patients and families affected by rare and life-threatening neurological genetic diseases. AveXis was acquired by Novartis on May 14, 2018.
AVXS Key Statistics
Stock Snapshot
As of today, AveXis(AVXS) shares are valued at $217.83. The company's market cap stands at 8.02B, with a P/E ratio of -17.65.
On 2026-06-08, AveXis(AVXS) stock opened at —, reached a high of —, and a low of —.
AveXis(AVXS) shares are trading with a volume of 0, against a daily average of 608.43K.
During the past year, AveXis(AVXS) stock moved between $65.54 at its lowest and $217.94 at its peak.
During the past year, AveXis(AVXS) stock moved between $65.54 at its lowest and $217.94 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.